QD
Therapeutic Areas
Biomissile Pipeline
| Drug | Indication | Phase |
|---|---|---|
| UDAB-M™ Platform Candidates | Various diseases with unmet needs | Preclinical |
Leadership Team at Biomissile
CT
Chao Tu, PhD
Co-founder, President & CEO
TY
Tianlei Ying, PhD
Co-founder & CSO
BX
Bin Xue
CFO
EW
Eric Wu, PhD
SVP, BD and Alliance Management
JQ
Jian Qiu, PhD
VP, Head of CMC
VL
Vivian Liu, PhD
VP, Medical & Clinical Affairs
SJ
Shibo Jiang, MD
Co-founder & Scientific Advisor
DD
Dimiter Dimitrov, PhD
Scientific Advisor